Target intelligence / Profile preview

Long intergenic non-protein coding RNA 652 (LINC00652)

Target
LINC00652
Molecular classification
Long non-coding RNA (lncRNA), specifically long intergenic non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 652 (LINC00652) is a long non-coding RNA (lncRNA) located in intergenic regions that does not code for protein. It is predominantly localized in the cytoplasm, where it is proposed to act as a competing endogenous RNA (ceRNA), regulating gene expression by binding multiple microRNAs. This lncRNA has been studied primarily in the context of acute lymphoblastic leukemia, where decreased levels are observed in patient samples and it may play a protective role, potentially influencing disease pathogenesis by modulating immune cell infiltration and several signaling pathways, including JAK/STAT and IL2-STAT5. No drugs are currently known to target LINC00652, and its utility as a therapeutic target has not been established[2]. Its aliases include HSPC072. No notable safety concerns or direct therapeutic interventions have been documented.

Other names
HSPC072LINC00652
02

Mechanism of action

Acts through ceRNA mechanism: sponges specific microRNAs, thereby derepressing target mRNAs involved in signaling pathways such as JAK/STAT, IL2-STAT5, apoptosis, and adipogenesis

03

Biological functions

Regulation of gene expression (primarily via ceRNA/competing endogenous RNA activity)Modulation of immune microenvironmentPotential involvement in apoptosis and cell signaling pathways
04

Disease associations

Cancer (notably a protective association in acute lymphoblastic leukemia [ALL])Possibly other cancer roles, but only ALL is specifically supported in search results
05

Biomarkers

Reduced levels may serve as a biomarker in ALL[2]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 652 (LINC00652).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 652 (LINC00652).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call